CDK9-IN-19
CDK9-IN-19 is a potent and selective CDK9 inhibitor (IC50 = 2.0 nM) with anti-proliferative activity in cancer cells. It demonstrates efficacy in MV4-11 xenograft models and is a research tool for studying acute myeloid leukemia (AML), offering moderate PK properties and low hERG liability.
Product Specifications
CAS Number
2479306-60-8
Field of Research
Cell Biology, Epigenetics & Chromatin
Smiles
C (C) (=O) C1=C (C=2C (=CC (NC=3N=C (C (F) =CN3) C4=C (OC) C=C (F) C=C4) =CC2) OC1=O) N5CCOCC5
Molecular Formula
C26H22F2N4O5
Molecular Weight
508.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-4980R-Cy7 100 µL
HIV p55+P6-Gag Polyclonal Antibody, Cy7 Conjugated
Sign In for Pricing
View Details K2150607 1.0 µg DNA
SIM2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
OR1087953-01 250 mg
4- (4-chloro-3,5-dimethylphenyl) tetrahydro-2H-pyran-4-ol
Sign In for Pricing
View Details